Netherton Syndrome

Harper's Textbook of Pediatric Dermatology: Third Edition

Volumn 2, Issue , 2011, Pages 1-10

  Di, Wei Li ^a   Harper, John ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Failure to thrive, major problem in first year of life; Gene therapy potential high efficiency gene transfer system; Immunological abnormalities and infections cutaneous, sinus and chest infections; Netherton syndrome; Netherton syndrome (OMIM 256500) or comel netherton syndrome; Netherton syndrome, affecting estimated 1 in 200,000 babies; Netherton syndrome, equal sex distribution female predominance; Netherton syndrome, first days of life congenital ichthyosiform erythroderma; Neurodevelopment normal in netherton syndrome; Staining for LEKTI protein netherton syndrome, polyclonal antibody

Indexed keywords

EID: 84886469749     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444345384.ch124     Document Type: Chapter

References (114)

1. Comel M. Ichthyosis linearis circumflexia. Dermatologica 1949;98: 133-6.
2. Netherton EW. A unique case of trichorrhexis nodosa; bamboo hairs. AMA Arch Derm 1958;78: 483-7.
3. Marshall J, Brede HD. Black piedra in a child with pili torti, bamboo hair and congenital ichthyosiform erythroderma. S Afr Med J 1961;35: 221-5.
4. Wilkinson RD, Curtis Ch, Hawk WA. Netherton's disease; trichorrhexis invaginata (bamboo hair), congential ichthyosiform erythroderma and the atopic diathesis. A histopathologic study. Arch Dermatol 1964;89: 46-54.
5. Altman J, Stroud J. Netherton's syndrome and ichthyosis linearis circumflexa. Arch Dermatol 1969;100: 550-8.
6. Mevorah B, Frenk E, Brooke EM. Ichthyosis linearis circumflexa comel. A clinico-statistical approach to its relationship with Netherton's syndrome. Dermatologica 1974;149: 201-9.
7. Bitoun E, Chavanas S, Irvine AD et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 2002;118: 352-61.
8. Pruszkowski A, Bodemer C, Fraitag S, Teillac-Hamel D, Amoric JC, de Prost Y. Neonatal and infantile erythrodermas: a retrospective study of 51 patients. Arch Dermatol 2000;136: 875-80.
9. Greene SL, Muller SA. Netherton's syndrome. Report of a case and review of the literature. J Am Acad Dermatol 1985;13: 329-37.
10. Traupe H. Guide to Clinical Diagnosis, Genetic Counselling, and Therapy. Berlin: Springer Verlag, 1985; 168-78.
11. Dupre A, Bonafe JL, Carrere S. [Comel's linear circumflex ichthyosis and Netherton's syndrome. General conceptions based on study of 4 cases (author's transl.)]. Ann Dermatol Venereol 1978;105: 49-54.
12. van Furth AM, Boontje RP, Louwers MJ, Canninga-van Dijk MR, Stoof TJ. [Netherton's syndrome in two sisters]. Ned Tijdschr Geneeskd 2002;146: 1087-90.
13. Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000;25: 141-2.
14. Sprecher E, Chavanas S, DiGiovanna JJ et al. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol 2001;117: 179-87.
15. Chao SC, Tsai YM, Lee JY. A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome. J Formos Med Assoc 2003;102: 418-23.
16. Komatsu N, Takata M, Otsuki N et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 2002;118: 436-43.
17. Raghunath M, Tontsidou L, Oji V et al. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol 2004;123: 474-83.
18. Shimomura Y, Sato N, Kariya N, Takatsuka S, Ito M. Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules. Br J Dermatol 2005;153: 1026-30.
19. Kilic G, Guler N, Ones U, Tamay Z, Guzel P. Netherton syndrome: report of identical twins presenting with severe atopic dermatitis. Eur J Pediatr 2006;165: 594-7.
20. Mizuno Y, Suga Y, Muramatsu S, Hasegawa T, Shimizu T, Ogawa H. A Japanese infant with localized ichthyosis linearis circumflexa on the palms and soles harbouring a compound heterozygous mutation in the SPINK5 gene. Br J Dermatol 2005;153: 661-3.
21. Mizuno Y, Suga Y, Haruna K et al. A case of a Japanese neonate with congenital ichthyosiform erythroderma diagnosed as Netherton syndrome. Clin Exp Dermatol 2006;31: 677-80.
22. Zhao Y, Ma ZH, Yang Y et al. SPINK5 gene mutation and decreased LEKTI activity in three Chinese patients with Netherton's syndrome. Clin Exp Dermatol 2007;32: 564-7.
23. Renner ED, Hartl D, Rylaarsdam S et al. Comel-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 2009;124: 536-43.
24. Tuysuz B, Ojalvo D, Mat C et al. A new SPINK5 donor splice site mutation in siblings with Netherton syndrome. Acta Derm Venereol 2010;90: 95-6.
25. Di WL. Larcher F, Senemova E et al. Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome derived skin grafts. Mol Ther 2010 Sep 28. [Epub ahead of print].
26. Magert HJ, Standker L, Kreutzmann P et al. LEKTI, a novel 15 - domain type of human serine proteinase inhibitor. J Biol Chem 1999;274: 21499-502.
27. Bitoun E, Micheloni A, Lamant L et al. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 2003; 12:2417-30.
28. Deraison C, Bonnart C, Lopez F et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 2007;18: 3607-19.
29. Jayakumar A, Kang Y, Henderson Y et al. Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution. Arch Biochem Biophys 2005;435: 89-102.
30. Egelrud T, Brattsand M, Kreutzmann P et al. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol 2005;153: 1200-3.
31. Jayakumar A, Kang Y, Mitsudo K et al. Expression of LEKTI domains 6-9'in the baculovirus expression system: recombinant LEKTI domains 6-9'inhibit trypsin and subtilisin A. Protein Expr Purif 2004;35: 93-101.
32. Mitsudo K, Jayakumar A, Henderson Y et al. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. Biochemistry 2003;42: 3874-81.
33. Borgono CA, Michael IP, Komatsu N et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007;282: 3640-52.
34. Caubet C, Jonca N, Brattsand M et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004;122: 1235-44.
35. Sales KU, Masedunskas A, Bey AL et al. Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome. Nat Genet 2010;42: 676-83.
36. Descargues P, Deraison C, Prost C et al. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin-and chymotrypsin-like hyperactivity in Netherton syndrome. J Invest Dermatol 2006; 126 (7): 1622-32.
37. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003;121: 345-53.
38. Briot A, Deraison C, Lacroix M et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009; 206:1135-47.
39. Bonnart C, Deraison C, Lacroix M et al. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 2010;120: 871-82.
40. Netzel-Arnett S, Currie BM, Szabo R et al. Evidence for a matriptase - prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem 2006;281: 32941-5.
41. Kilpatrick LM, Harris RL, Owen KA et al. Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 2006;108: 2616-23.
42. Hosomi N, Fukai K, Nakanishi T, Funaki S, Ishii M. Caspase-1 activity of stratum corneum and serum interleukin-18 level are increased in patients with Netherton syndrome. Br J Dermatol 2008; 159:744-6.
43. Bennett K, Callard R, Heywood W et al. New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res 2010;9: 4289-94.
44. Kabesch M, Carr D, Weiland SK, von Mutius E. Association between polymorphisms in serine protease inhibitor, kazal type 5 and asthma phenotypes in a large German population sample. Clin Exp Allergy 2004;34: 340-5.
45. Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003;148: 665-9.
46. Nishio Y, Noguchi E, Shibasaki M et al. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 2003;4: 515-17.
47. Walley AJ, Chavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29: 175-8.
48. Kusunoki T, Okafuji I, Yoshioka T et al. SPINK5 polymorphism is associated with disease severity and food allergy in children with atopic dermatitis. J Allergy Clin Immunol 2005;115: 636-8.
49. Hubiche T, Ged C, Benard A et al. Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol 2007;87: 499-505.
50. Weidinger S, Baurecht H, Wagenpfeil S, et al. Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol 2008;122: 560-8.
51. Fartasch M, Williams ML, Elias PM. Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 1999;135: 823-32.
52. Frenk E, Mevorah B. Ichthyosis linearis circumflexa Comel with Trichorrhexis invaginata (Netherton's Syndrome): an ultrastructural study of the skin changes. Arch Dermatol Forsch 1972;245: 42-9.
53. Muller FB, Hausser I, Berg D et al. Genetic analysis of a severe case of Netherton syndrome and application for prenatal testing. Br J Dermatol 2002;146: 495-9.
54. Thorne EG, Zelickson AS, Mottaz JH, Katz HI, Deaton BH. Netherton's syndrome: an electronmicroscopic study. Arch Dermatol Res 1975;253: 177-83.
55. Jones SK, Thomason LM, Surbrugg SK, Weston WL. Neonatal hypernatraemia in two siblings with Netherton's syndrome. Br J Dermatol 1986;114: 741-3.
56. Hausser I, Anton-Lamprecht I, Hartschuh W, Petzoldt D. Netherton's syndrome: ultrastructure of the active lesion under retinoid therapy. Arch Dermatol Res 1989;281: 165-72.
57. Judge MR, Morgan G, Harper JI. A clinical and immunological study of Netherton's syndrome. Br J Dermatol 1994;131: 615-21.
58. Smith DL, Smith JG, Wong SW, deShazo RD. Netherton's syndrome. Br J Dermatol 1995;133: 153-4.
59. De WK, Ferster A, Sass U, Andre J, Stene JJ, Song M. Netherton's syndrome: a severe neonatal disease. A case report. Dermatology 1996;192: 400-2.
60. Plantin P, Delaire P, Guillet MH, Labouche F, Guillet G. [Netherton's syndrome. Current aspects. Apropos of 9 cases]. Ann Dermatol Venereol 1991;118: 525-30.
61. Sardy M, Fay A, Karpati S, Horvath A. Comel-Netherton syndrome and peeling skin syndrome type B: overlapping syndromes or one entity? Int J Dermatol 2002;41: 264-8.
62. Smith DL, Smith JG, Wong SW, deShazo RD. Netherton's syndrome: a syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 1995;95: 116-23.
63. Folster-Holst R, Swensson O, Stockfleth E, Monig H, Mrowietz U, Christophers E. Comel-Netherton syndrome complicated by papillomatous skin lesions containing human papillomaviruses 51 and 52 and plane warts containing human papillomavirus 16. Br J Dermatol 1999;140: 1139-43.
64. Sedlacek V, Krenar J. [Symptomatology of Comel's linear circumflex ichthyosis (a case associated with genito-anal papillomatosis)]. Hautarzt 1971;22: 390-7.
65. Weber F, Fuchs PG, Pfister HJ, Hintner H, Fritsch P, Hoepfl R. Human papillomavirus infection in Netherton's syndrome. Br J Dermatol 2001;144: 1044-9.
66. Hintner H, Jaschke E, Fritsch P. [Netherton syndrome: weakened immunity, generalized verrucosis and carcinogenesis]. Hautarzt 1980;31: 428-32.
67. Kubler HC, Kuhn W, Rummel HH, Kaufmann I, Kaufmann M. [Development of cancer (vulvar cancer) in the Netherton syndrome (ichthyosis, hair anomalies, atopic diathesis)]. Geburtshilfe Frauenheilkd 1987;47: 742-4.
68. Saghari S, Woolery-Lloyd H, Nouri K. Squamous cell carcinoma in a patient with Netherton's syndrome. Int J Dermatol 2002; 41:415-16.
69. Krasagakis K, Ioannidou DJ, Stephanidou M, Manios A, Panayiotides JG, Tosca AD. Early development of multiple epithelial neoplasms in Netherton syndrome. Dermatology 2003;207: 182-4.
70. Stevanovic DV. Multiple defects of the hair shaft in Netherton's disease. Association with ichthyosis linearis circumflexa. Br J Dermatol 1969;81: 851-7.
71. Lurie R, Hodak E, Ginzburg A, David M. Trichorrhexis nodosa: a manifestation of hypothyroidism. Cutis 1996;57: 358-9.
72. Taylor CJ, Green SH. Menkes'syndrome (trichopoliodystrophy): use of scanning electron-microscope in diagnosis and carrier identification. Dev Med Child Neurol 1981;23: 361-8.
73. Silengo M, Pietragalla A, Jarre L. Trichorrhexis nodosa and lip pits in autosomal dominant ectodermal dysplasia-central nervous system malformation syndrome. Am J Med Genet 1997; 71:226-8.
74. Silengo M, Valenzise M, Spada M et al. Hair anomalies as a sign of mitochondrial disease. Eur J Pediatr 2003;162: 459-61.
75. Shelley WB, Rawnsley HM. Aminogenic alopecia. Trans Assoc Am Physicians 1966;79: 146-56.
76. Ito M, Ito K, Hashimoto K. Pathogenesis in trichorrhexis invaginata (bamboo hair). J Invest Dermatol 1984;83: 1-6.
77. Taneda A, Ogawa H, Hashimoto K. The histochemical demonstration of protein-bound sulfhydryl groups and disulfide bonds in human hair by a new staining method (DACM staining). J Invest Dermatol 1980;75: 365-9.
78. Bitoun E, Bodemer C, Amiel J et al. Prenatal diagnosis of a lethal form of Netherton syndrome by SPINK5 mutation analysis. Prenat Diagn 2002;22: 121-6.
79. de Berker DA, Paige DG, Ferguson DJ, Dawber RP. Golf tee hairs in Netherton disease. Pediatr Dermatol 1995;12: 7-11.
80. Powell J, Dawber RP, Ferguson DJ, Griffiths WA. Netherton's syndrome: increased likelihood of diagnosis by examining eyebrow hairs. Br J Dermatol 1999;141: 544-6.
81. Menne T, Weisman K. Canestick lesion of vellus hair in Netherton's syndrome. Arch Dermatol 1985;121: 451.
82. Adamson JE, Marten RH. Ichthyosis linearis circumflexa and Netherton's syndrome with idiopathic dwarfism. Proc R Soc Med 1973; 66:624-5.
83. Caputo R, Vanotti P, Bertani E. Netherton's syndrome in two adult brothers. Arch Dermatol 1984;120: 220-2.
84. Brodin MB, Porter PS. Nertherton's syndrome. Cutis 1980; 26:185-8.
85. Dawber R, Comaish S. Scanning electron microscopy of normal and abnormal hair shafts. Arch Dermatol 1970;101: 316-22.
86. Leonard JN, Gummer CL, Dawber RP. Generalized trichorrhexis nodosa. Br J Dermatol 1980;103: 85-90.
87. Kurwa AR, Abdel-Aziz AH. Pili torti-congenital and acquired. Acta Derm Venereol 1973;53: 385-92.
88. Selvaag E, Aas AM, Heide S. Structural hair shaft abnormalities in hypomelanosis of Ito and other ectodermal dysplasias. Acta Paediatr 2000;89: 610-12.
89. Krafchik BR. What syndrome is this? Netherton syndrome. Pediatr Dermatol 1992;9: 157-60.
90. Nikulin A, Salamon T. [The origin of the hair nodosities in Netherton' s disease. (Polarization microscope studies)]. Z Haut Geschlechtskr 1969;44: 1015-22.
91. Stankler L, Cochrane T. Netherton's disease in two sisters. Br J Dermatol 1967;79: 187-96.
92. Gupta AK, Love P, Rasmussen JE. Hair abnormalities and a rash with a double-edged scale. Netherton's syndrome. Arch Dermatol 1986; 122: 1201, 1203-4.
93. Kassis V, Nielsen JM, Klem-Thomsen H, Dahl-Christensen J, Wadskov S. Familial Netherton's disease. Cutis 1986;38: 175-8.
94. Renz H, Brodie C, Bradley K, Leung DY, Gelfand EW. Enhancement of IgE production by anti-CD40 antibody in atopic dermatitis. J Allergy Clin Immunol 1994;93: 658-68.
95. Stryk S, Siegfried EC, Knutsen AP. Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome . Pediatr Dermatol 1999;16: 19-22.
96. Knutsen AP. Chronic sinusitis in children. Pediatr Asthma Allerg Immunol 1997;11: 147-69.
97. Arslanagic N, Arslanagic R. [Netherton syndrome with recurrent herpes of facial skin]. Medicinski Arhiv (Sarajevo) 2002;56: 221-4.
98. Nicholls S, Patel HC, Jones M. Recurrent bacterial vaginosis and Netherton' s syndrome. Int J STD AIDS 1999;10: 202-3.
99. De WK, Ferster A, Sass U, Andre J, Stene JJ, Song M. Netherton's syndrome: a severe neonatal disease. A case report. Dermatology 1996;192: 400-2.
100. Gross TP, Khurana RK, Higgins T, Nkowane BS, Hirsch RL. Vaccine - associated poliomyelitis in a household contact with Netherton's syndrome receiving long-term steroid therapy. Am J Med 1987; 83:797-800.
101. Hausser I, Anton-Lamprecht I. Severe congenital generalized exfoliative erythroderma in newborns and infants: a possible sign of Netherton syndrome. Pediatr Dermatol 1996;13: 183-99.
102. Pradeaux L, Olives JP, Bonafe JL, Le TC, Pigeon P, Ghisolfi J. [Digestive and nutritional manifestations of Netherton's syndrome]. Arch Fr Pediatr 1991;48: 95-8.
103. Greig D, Wishart J. Growth abnormality in Netherton's syndrome. Australas J Dermatol 1982;23: 27-31.
104. Stoll C, Alembik Y, Tchomakov D et al. Severe hypernatremic dehydration in an infant with Netherton syndrome. Genet Couns 2001;12: 237-43.
105. Ergin H, Kilic I, Tekinalp G. Netherton's syndrome and neonatal hypernatremia. A case report. Turk J Pediatr 1997; 39:409-13.
106. Pohl M, Zimmerhackl LB, Hausser I et al. Acute bilateral renal vein thrombosis complicating Netherton syndrome. Eur J Pediatr 1998;157: 157-60.
107. Yerebakan O, Uguz A, Keser I et al. Netherton syndrome associated with idiopathic congenital hemihypertrophy. Pediatr Dermatol 2002;19: 345-8.
108. Julius CE, Keeran M. Netherton's syndrome in a male. Arch Dermatol 1971;104: 422-4.
109. Glover MT, Atherton DJ, Levinsky RJ. Syndrome of erythroderma, failure to thrive, and diarrhea in infancy: a manifestation of immunodeficiency. Pediatrics 1988;81: 66-72.
110. Ong C, O'Toole EA, Ghali L et al. LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome. Br J Dermatol 2004;151: 1253-7.
111. Allen A, Siegfried E, Silverman R et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001;137: 747-50.
112. Bens G, Boralevi F, Buzenet C, Taieb A. Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption. Br J Dermatol 2003;149: 224-6.
113. Ferrari S, Pellegrini G, Matsui T, Mavilio F, De Luca M. Towards a gene therapy clinical trial for epidermolysis bullosa. Rev Recent Clin Trials 2006;1: 155-62.
114. Mavilio F, Pellegrini G, Ferrari S et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006;12: 1397-402.